JP2003506416A5 - - Google Patents

Download PDF

Info

Publication number
JP2003506416A5
JP2003506416A5 JP2001514981A JP2001514981A JP2003506416A5 JP 2003506416 A5 JP2003506416 A5 JP 2003506416A5 JP 2001514981 A JP2001514981 A JP 2001514981A JP 2001514981 A JP2001514981 A JP 2001514981A JP 2003506416 A5 JP2003506416 A5 JP 2003506416A5
Authority
JP
Japan
Prior art keywords
moxifloxacin
moxifloxacin hydrochloride
aqueous solution
aqueous
converted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001514981A
Other languages
English (en)
Other versions
JP2003506416A (ja
JP5522877B2 (ja
Filing date
Publication date
Priority claimed from DE19937116A external-priority patent/DE19937116A1/de
Application filed filed Critical
Publication of JP2003506416A publication Critical patent/JP2003506416A/ja
Publication of JP2003506416A5 publication Critical patent/JP2003506416A5/ja
Application granted granted Critical
Publication of JP5522877B2 publication Critical patent/JP5522877B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Description

【特許請求の範囲】
【請求項１】
塩酸モキシフロキサシン０．０４％−０．４％（ｗ／ｖ）（モキシフロキサシン量に換算）と塩化ナトリウム０．４％−０.９％（ｗ／ｖ）を含んで成る水性製剤。
【請求項２】
初めに塩酸モキシフロキサシン水溶液を調製し、次いで塩化ナトリウムを添加し、そして溶解する塩酸モキシフロキサシン水性製剤の調製方法。
【請求項３】
非経口投与用医薬品を調製するための０．４％（ｗ／ｖ）より多く、２．４％（ｗ／ｖ）までの塩酸モキシフロキサシン濃度（モキシフロキサシン量に換算）を含む塩酸モキシフロキサシン水溶液の使用。
【請求項４】
０．４％（ｗ／ｖ）より多く、２．４％（ｗ／ｖ）までの塩酸モキシフロキサシン濃度（モキシフロキサシン量に換算）を含む塩酸モキシフロキサシン水溶液と塩化ナトリウムを含む水溶液を相互に別々に含んで成る組み合わせ（ｃｏｍｂｉｎａｔｉｏｎ）調製物。
【請求項５】
人または動物の細菌感染症の予防または治療用医薬品を調製するための請求項１に記載の水性製剤の使用。
JP2001514981A 1999-08-06 2000-07-25 モキシフロキサシン／塩化ナトリウム製剤 Expired - Lifetime JP5522877B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19937116A DE19937116A1 (de) 1999-08-06 1999-08-06 Moxifloxacin Kochsalzformulierung
DE19937116.4 1999-08-06
PCT/EP2000/007098 WO2001010465A1 (de) 1999-08-06 2000-07-25 Moxifloxacin kochsalzformulierung

Publications (3)

Publication Number Publication Date
JP2003506416A JP2003506416A (ja) 2003-02-18
JP2003506416A5 true JP2003506416A5 (ja) 2007-09-06
JP5522877B2 JP5522877B2 (ja) 2014-06-18

Family

ID=7917417

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001514981A Expired - Lifetime JP5522877B2 (ja) 1999-08-06 2000-07-25 モキシフロキサシン／塩化ナトリウム製剤

Country Status (40)

Country Link
US (1) US6548079B1 (ja)
EP (1) EP1206281B1 (ja)
JP (1) JP5522877B2 (ja)
KR (1) KR100735788B1 (ja)
CN (1) CN1246039C (ja)
AR (1) AR025001A1 (ja)
AT (1) ATE270104T1 (ja)
AU (1) AU771058B2 (ja)
BG (1) BG65304B1 (ja)
BR (1) BRPI0013010B8 (ja)
CA (1) CA2378424C (ja)
CO (1) CO5190677A1 (ja)
CU (1) CU23367A3 (ja)
CZ (1) CZ298768B6 (ja)
DE (2) DE19937116A1 (ja)
DK (1) DK1206281T3 (ja)
EE (1) EE04771B1 (ja)
ES (1) ES2223549T3 (ja)
GT (1) GT200000123A (ja)
HK (1) HK1049615B (ja)
HN (1) HN2000000115A (ja)
HR (1) HRP20020198B1 (ja)
HU (1) HU229571B1 (ja)
IL (2) IL147553A0 (ja)
MA (1) MA25427A1 (ja)
MX (1) MXPA02001254A (ja)
MY (1) MY125356A (ja)
NO (1) NO320743B1 (ja)
NZ (1) NZ516969A (ja)
PE (1) PE20010400A1 (ja)
PL (1) PL198132B1 (ja)
PT (1) PT1206281E (ja)
RU (1) RU2260429C9 (ja)
SI (1) SI1206281T1 (ja)
SK (1) SK285650B6 (ja)
TW (1) TWI238719B (ja)
UA (1) UA72268C2 (ja)
UY (1) UY26269A1 (ja)
WO (1) WO2001010465A1 (ja)
ZA (1) ZA200200215B (ja)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19937116A1 (de) 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
DE10218328A1 (de) * 2002-03-05 2003-09-25 Humboldt Uni Zu Berlin Medizin Mittel zur präventiven Therapie nach akutem Schlaganfall
US20040197408A1 (en) * 2002-12-30 2004-10-07 Angiotech International Ag Amino acids in micelle preparation
WO2006015545A1 (fr) * 2004-08-11 2006-02-16 Shenzhen Tys R & D Co., Ltd. Capsule de gelatine de moxifloxacin et procede pour sa preparation
JO2752B1 (en) * 2005-06-28 2014-03-15 شركة جانسين فارماسوتيكا ان. في Quinoline derivatives acting as antibacterial agents
JO3270B1 (ar) * 2005-06-28 2018-09-16 Janssen Pharmaceutica Nv مشتقات كوينولين بصفة عوامل مضادة للبكتيريا
DE102006031175A1 (de) * 2006-07-06 2008-01-10 Bayer Healthcare Ag Wässrige Arzneimittelformulierung von 4-[((4-Carboxybutyl)-(2[(4-phenethyl-benzyl)oxy]-phenethyl)amino)methyl]benzoesäur
US7537532B2 (en) * 2007-05-16 2009-05-26 Young Carl D Handle for implement and method
CN101787022B (zh) * 2009-10-09 2012-08-22 浙江医药股份有限公司新昌制药厂 一种喹啉羧酸盐酸盐一水合物晶型及其制备方法
WO2011086577A2 (en) * 2010-01-12 2011-07-21 Msn Laboratories Limited Pharmaceutical composition of moxifloxacin and its pharmaceutically acceptable salts
CN101836950A (zh) * 2010-03-12 2010-09-22 陕西合成药业有限公司 一种盐酸莫西沙星葡萄糖注射液及其制备方法和用途
CN101972257B (zh) * 2010-09-10 2015-08-05 杭州民生药业有限公司 一种含有莫西沙星的药物组合物
CN102093349B (zh) * 2011-01-17 2012-03-07 南京新港医药有限公司 一种工业化生产盐酸莫西沙星的方法
CN102100666B (zh) * 2011-01-17 2012-07-18 南京新港医药有限公司 一种新的盐酸莫西沙星注射剂
CN102688183B (zh) * 2011-03-21 2016-04-06 重庆医药工业研究院有限责任公司 一种稳定的盐酸莫西沙星注射剂
KR101435244B1 (ko) * 2011-04-12 2014-08-29 씨제이헬스케어 주식회사 목시플록사신 수성 제형 및 이의 제조방법
KR101327904B1 (ko) * 2011-08-16 2013-11-13 대한약품공업 주식회사 목시플록사신 염산염의 주사제형
RU2472507C1 (ru) * 2012-02-01 2013-01-20 Закрытое акционерное общество "Брынцалов-А" Водный состав на основе моксифлоксацина для парентерального введения
CN102600093B (zh) * 2012-04-11 2013-06-05 南京优科生物医药有限公司 一种莫西沙星片剂及其制备方法
GR1008168B (el) 2013-03-14 2014-04-08 "Φαρματεν Α.Β.Ε.Ε.", Παρεντερικο σκευασμα αντιβακτηριακου παραγοντα φθοριοκινολονης και μεθοδος για την παρασκευη αυτου
CN103191056B (zh) * 2013-04-28 2014-10-22 南京海融医药科技有限公司 莫西沙星的口服液体制剂及其制备方法和应用
WO2015093669A1 (ko) * 2013-12-20 2015-06-25 씨제이헬스케어 주식회사 목시플록사신 수성 제형 및 이의 제조방법
CN103976944A (zh) * 2014-05-16 2014-08-13 成都青山利康药业有限公司 一种盐酸莫西沙星氯化钠注射液
CN104771359A (zh) * 2015-04-02 2015-07-15 南京正大天晴制药有限公司 一种稳定的盐酸莫西沙星注射液
CN105640876B (zh) * 2016-01-07 2019-04-12 天津红日药业股份有限公司 一种盐酸莫西沙星氯化钠注射液的制备工艺
US20180318319A1 (en) 2017-05-04 2018-11-08 Ocular Science, Inc. Compositions and Methods for Treating Eyes and Methods of Preparation
EP3578182A1 (en) * 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulations containing triazinones and iron with a low amount of free iron ions
US11071724B2 (en) 2019-05-17 2021-07-27 Ocular Science, Inc. Compositions and methods for treating presbyopia
CN111388415A (zh) * 2020-03-19 2020-07-10 石家庄四药有限公司 一种盐酸莫西沙星氯化钠注射液及其制备方法
CN116490211A (zh) 2020-10-29 2023-07-25 株式会社泰俊制药 眼用组合物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3537761A1 (de) 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
JPH01258620A (ja) * 1988-04-08 1989-10-16 Dai Ichi Seiyaku Co Ltd 耳疾患用局所製剤
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
WO1990013542A1 (fr) * 1989-04-28 1990-11-15 Daiichi Pharmaceutical Co., Ltd. Medicament anti-hiv
WO1991009525A1 (en) 1989-12-29 1991-07-11 Abbott Laboratories Quinolone carboxylic acid--metal ion--acid complexes
US5084276A (en) 1990-01-05 1992-01-28 Abbott Laboratories Quinolone carboxylic acid compositions with polymeric additive to reduce vein irritation
FR2681863B1 (fr) 1991-09-27 1995-02-03 Rhone Dpc Europ Solution de sparfloxacine sa preparation et sel la constituant.
DE4306417A1 (de) * 1993-03-02 1994-09-08 Grace Gmbh Vorrichtung und Verfahren zum Verbrennen oxidierbarer Bestandteile in einem zu reinigenden Trägergas
CA2152828A1 (en) * 1993-03-16 1994-07-07 Shin-Ichi Uesato 8-methoxy-quinolonecarboxylic acid derivatives
KR960000223A (ko) 1994-06-08 1996-01-25 김정순 신규한 피리돈 카르복실산 화합물을 함유한 수용액 및 이의 제조방법
SK284412B6 (sk) 1995-12-21 2005-03-04 Pfizer Inc. Vodný farmaceutický roztok vhodný na injekčné podávanie hostiteľovi
JPH1192375A (ja) * 1997-09-25 1999-04-06 Morinaga Milk Ind Co Ltd ニューキノロン系抗菌剤の抗菌性を増強させる抗菌剤
AR020661A1 (es) * 1998-09-30 2002-05-22 Alcon Lab Inc Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento
KR100650489B1 (ko) * 1998-11-10 2006-11-28 바이엘 헬스케어 아게 목시플록사신 제약 제제
DE19937115A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Wäßrige Arzneimittelformulierung von Moxifloxacin oder Salzen davon
DE19937116A1 (de) 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung

Similar Documents

Publication Publication Date Title
JP2003506416A5 (ja)
CA2378424A1 (en) Moxifloxacin formulation containing common salt
RU2002106399A (ru) Составы моксифлоксацина, содержащие поваренную соль
JP2003528798A5 (ja)
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
JP2008526757A5 (ja)
JP2002363097A5 (ja)
AP1760A (en) Platinum derivative pharmaceutical formulations.
NO941276L (no) Lipofile, oligosakkaride antibiotikasaltpreparater
NO20063277L (no) Farmasoytisk sammensetning av vinflunin som er ment for parenteral administrering, fremstillingsmate og anvendelse derav
CY1107819T1 (el) Φαρμακευτικη διαμορφωση της ολανζαπινης
DK1561460T3 (da) Nanopartikler til indgivelse af aktive ingredienser, fremgangsmåde til fremstilling af nævnte partikler og komposition, som omfatter det samme
CA2389032A1 (en) Preventive or therapeutic agents for inflammatory diseases of intestine
JP2002537232A5 (ja)
JP2002515439A5 (ja)
JP2002537246A5 (ja)
JP2003517462A5 (ja)
MXPA01007210A (es) Agente para el tratamiento de enfermedad de parkinson que comprende un agente que mejora la funcion del astrocito como ingrediente activo.
WO2001045727A3 (en) Stabilized veterinary compositions comprising more than one antiviral agent
WO2001032159A3 (en) Methods and formulations for the treatment of infectious bursal disease in avian subjects
WO2016144121A2 (ko) 케라틴 조직의 진균감염증 치료를 위한 약제학적 조성물
JP2002029998A5 (ja)
JP2004196748A (ja) キトサン含有消炎鎮痛皮膚外用液剤
TH82489B (th) สูตรผสมของมอกซิฟลอกซาซิน/โซเดียม คลอไรด์